LCN2 and type 2 diabetes mellitus: In animal models of metabolic inflammation, T2DM, or nonalcoholic steatohepatitis, increased LCN2 expression promotes inflammation through the recruitment of inflammatory cells and induction of proinflammatory cytokines (Moschen et al., 2017).